농구 - Club Friendlies - BC 쿠타이시 vs VSA - 2024-10-01
Item 7.01 Regulation FD Disclosure · AAR CORP.’s Vice President, Chief Financial Officer and Treasurer, Michael J. Sharp, presented at the Cowen and Company 37th Annual Aerospace/Defense & Transportation Conference on Thursday, February 4, 2016 in New York City. Attached as Exhibit 99.1 are the slides used by Mr. Sharp in his presentation. The information in this Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed to be “filed” for the purposes of Section 18 of t...
Disclaimer ; Certain statements in this presentation may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s expectations; beliefs; plans; strategies; investments; financial performance; expected benefits of new initiatives; content, products, experiences or service offerings (including timing and nature); priorities or performance; businesses and assets; future investments and crea...
안녕하세요 밴쿠버 김옥란 유학원 브라이언입니다. 캐나다 BC주의 VSA에 대해서 알아보겠씁니다. Vehicle Sales Authority of BC 이 기관은 Licensed Salesperson and Dealer을 관리하는 곳입니다. 차량을 구입할 때 문제나 구매하고 나서 문제점이 발생 했을 때 딜러들이 차를 팔 때처럼 친절하지가 않을 때..
Item 7.01 Regulation FD Disclosure ; AAR CORP.’s Vice President, Chief Financial Officer and Treasurer, John C. Fortson, presented at the Jeffries 2014 Global Industrials Conference on Thursday, August 14, 2014 in New York City. ; Attached as Exhibit 99.1 are the slides used by Mr. Fortson in his presentation.
Georgia Dudu Dadiani Memorial, 10/04 22:00, VSA v Amra Gagra, 82-71 ; Georgia Dudu Dadiani Memorial, 10/03 20:00, VSA v Margveti, 88-71 ; Club Friendlies, 10/01 20:00, BC 쿠타이시 v VSA, 84-89 ; A-League, 04/08 21:30, 수후미 v VSA, 67-78
Ensure compliance and success with VSA licensing. Trust Vehicle Sales Authority for seamless operations in the BC auto industry
UNITED STATES SECURITIES AND EXCHANGE COMMISSION ; Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ; o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ; o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Oracle_Fusio-lease_1_11.1.1OA�TOA�TBOOKMOBI]� ���$F)�/W 4�:L?�E5J�P�V^\Pb�i*q4 w�")$��&�(�*��,�.��0��2�4�6Ț8�e:�E<��Y>�J...
Item 7.01 Regulation FD Disclosure. On January 3, 2019, BioXcel Therapeutics, Inc. (the “Company”) held an investor conference call and discussed the results of the study described in Item 8.01 below and the Company’s BXCL501 program. In connection with the investor call, the Company prepared presentation materials (“the Presentation Materials”), a copy of which are furnished as Exhibit 99.1 to this current report on Form 8-K. The call will be available via a live, listen-only webcast ...